Print-only header

IPPH Research - Formulation

“Formulation” combines a drug with biologically inert materials to create a product with the desired properties. Properties that can be controlled by formulation include apparent solubility and dissolution rate, chemical stability, protein aggregation, and crystal polymorphic form. Research in formulation addresses the rates and mechanisms of chemical degradation reactions, the nucleation and growth of pharmaceutical crystals, and the development of novel excipients that stabilize the drug. The Department of Industrial and Physical Pharmacy is a world leader in developing fundamental understanding and new technologies for formulating pharmaceutical solids.

  • Stephen R. Byrn (Charles B. Jordan Professor) – solid state formulation and stability of small molecules, pediatric formulation, reduced dose formulation
  • Keith Chadwick (Assistant Professor) – heterogeneous nucleation, control of polymorphism
  • Tonglei Li (Allen Chao Professor) – computational prediction of crystal structure, nanocrystals, amorphous-crystalline transitions
  • Lynne S. Taylor (Professor) – amorphous solids, role of moisture in pharmaceutical solids, development of analytical methods to characterize solids
  • Elizabeth M. Topp (Dane O. Kildsig Chair and Department Head) – solid-state formulation and stability of biologics, control of protein aggregation
E-mail Webmaster
Maintained by: College of Pharmacy
This page was last modified at 9:29 AM on July 9, 2013
Purdue University, Department of Industrial and Physical Pharmacy
575 Stadium Mall Drive, West Lafayette, IN 47907-2091,  (765) 494-1450, FAX: (765) 494-6545
© 2003-2014 Purdue University | An equal access/equal opportunity university | Copyright Complaints
If you have trouble accessing this page because of a disability, please contact us at webmaster@pharmacy.purdue.edu.